Sativa Group plc opened its first store of a planned national chain of Goodbody Wellness specialist retail outlets on Saturday.
The 60.67 sq. m. CBD wellness retail store opened in Bath. It provides a range of over 50 CBD products, and offers consumers the opportunity to try CBD infused coffee and tea.
Customers can also buy CBD coffee in bean form, as well as tea, to enjoy from the comfort of their own homes.
The store was launched on Friday evening my Crispin Blunt MP and Co-chair of the All Party Parliamentary Group for Drug Policy Reform.
Sativa Group said that, for the first weekend of trading, footfall, turnover and average transaction value were ahead of expectations. The company has emphasised, however, that this is by no means a group forecast.
The store also boasts highly trained staff who can offer customers advice on the CBD product ranges available, as well as the best ways to use these products.
CBD is said to boost the body’s endo-cannabinoid system, which works to restore homeostasis and balance.
CBD is not psychoactive; it does not get users high. The main psychoactive ingredient in marijuana is THC. CBD does, however, offer a range of anti-inflammatory, anti-pain and anti-psychotic properties.
All of the products available pass scientific laboratory testing by the company’s own independent laboratory and comply with legal guidelines.
“Goodbody Wellness is the UKs first prestige CBD store and the Bath launch was a great success, with customer feedback being that the format is exactly what they wanted,” said Geremy Thomas, Sativa’s Chief Executive and Founder.
“This opening marks the start of what we intend to be a major high street journey for Goodbody as CBD wellness products gain wider acceptance in the UK,” Geremy Thomas continued.
“Our product development and manufacturing capability allows multiple routes to market and the roll out of our Goodbody store network will drive revenues. Bath is the first of three pilot stores after which the company intends to roll-out a national franchise network, because the directors believe that this is the fastest and least capital-intensive route to a national footprint.”
As the medical use of the drug sees various breakthroughs, the sector could be the next hot sector to invest in.